Novartis AG Statistics
Share Statistics
Novartis AG has 1.96B shares outstanding. The number of shares has increased by -4.82% in one year.
| Shares Outstanding | 1.96B |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | 0% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 1.96B |
| Failed to Deliver (FTD) Shares | 497.66K |
| FTD / Avg. Volume | 45.01% |
Short Selling Information
The latest short interest is 4.76M, so 0.24% of the outstanding shares have been sold short.
| Short Interest | 4.76M |
| Short % of Shares Out | 0.24% |
| Short % of Float | 0.24% |
| Short Ratio (days to cover) | 4.28 |
Valuation Ratios
The PE ratio is 14.2 and the forward PE ratio is 12.46. Novartis AG's PEG ratio is 0.76.
| PE Ratio | 14.2 |
| Forward PE | 12.46 |
| PS Ratio | 4.52 |
| Forward PS | 3.7 |
| PB Ratio | 4.52 |
| P/FCF Ratio | 18.02 |
| PEG Ratio | 0.76 |
Enterprise Valuation
Novartis AG has an Enterprise Value (EV) of 222.71B.
| EV / Earnings | 15 |
| EV / Sales | 4.77 |
| EV / EBITDA | 12.18 |
| EV / EBIT | 22.8 |
| EV / FCF | 19.03 |
Financial Position
The company has a current ratio of 1.16, with a Debt / Equity ratio of 0.53.
| Current Ratio | 1.16 |
| Quick Ratio | 0.93 |
| Debt / Equity | 0.53 |
| Total Debt / Capitalization | 34.44 |
| Cash Flow / Debt | 0.59 |
| Interest Coverage | 11.43 |
Financial Efficiency
Return on equity (ROE) is 0.32% and return on capital (ROIC) is 12.56%.
| Return on Equity (ROE) | 0.32% |
| Return on Assets (ROA) | 0.15% |
| Return on Capital (ROIC) | 12.56% |
| Revenue Per Employee | 613.49K |
| Profits Per Employee | 195.25K |
| Employee Count | 76.06K |
| Asset Turnover | 0.47 |
| Inventory Turnover | 2.11 |
Taxes
| Income Tax | 551.00M |
| Effective Tax Rate | 0.06 |
Stock Price Statistics
The stock price has increased by 0.97% in the last 52 weeks. The beta is 0.51, so Novartis AG's price volatility has been higher than the market average.
| Beta | 0.51 |
| 52-Week Price Change | 0.97% |
| 50-Day Moving Average | 108.43 |
| 200-Day Moving Average | 106.53 |
| Relative Strength Index (RSI) | 24.46 |
| Average Volume (20 Days) | 1.11M |
Income Statement
In the last 12 months, Novartis AG had revenue of $46.66B and earned $14.85B in profits. Earnings per share was $7.15.
| Revenue | 46.66B |
| Gross Profit | 34.19B |
| Operating Income | 9.77B |
| Net Income | 14.85B |
| EBITDA | 18.29B |
| EBIT | 9.77B |
| Earnings Per Share (EPS) | 7.15 |
Balance Sheet
The company has $13.39B in cash and $26.35B in debt, giving a net cash position of -$12.96B.
| Cash & Cash Equivalents | 13.39B |
| Total Debt | 26.35B |
| Net Cash | -12.96B |
| Retained Earnings | 49.65B |
| Total Assets | 103.52B |
| Working Capital | 3.13B |
Cash Flow
In the last 12 months, operating cash flow was $14.46B and capital expenditures -$2.75B, giving a free cash flow of $11.71B.
| Operating Cash Flow | 14.46B |
| Capital Expenditures | -2.75B |
| Free Cash Flow | 11.71B |
| FCF Per Share | 5.6 |
Margins
Gross margin is 73.27%, with operating and profit margins of 20.94% and 31.83%.
| Gross Margin | 73.27% |
| Operating Margin | 20.94% |
| Pretax Margin | 19.55% |
| Profit Margin | 31.83% |
| EBITDA Margin | 39.19% |
| EBIT Margin | 20.94% |
| FCF Margin | 25.09% |
Dividends & Yields
NVS pays an annual dividend of $3.78, which amounts to a dividend yield of 3.83%.
| Dividend Per Share | $3.78 |
| Dividend Yield | 3.83% |
| Dividend Growth (YoY) | 8.95% |
| Payout Ratio | 65.97% |
| Earnings Yield | 7.27% |
| FCF Yield | 6.08% |
Analyst Forecast
The average price target for NVS is $120.5, which is 22.5% higher than the current price. The consensus rating is "Hold".
| Price Target | $120.5 |
| Price Target Difference | 22.5% |
| Analyst Consensus | Hold |
| Analyst Count | 6 |
Stock Splits
The last stock split was on Apr 9, 2019. It was a forward split with a ratio of 279:250.
| Last Split Date | Apr 9, 2019 |
| Split Type | forward |
| Split Ratio | 279:250 |
Scores
| Altman Z-Score | 3.51 |
| Piotroski F-Score | 7 |